Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 350 of 458 publications.

Zimovetz EA, Wolowacz SE, Classi PM, Birt J. Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Eff Resour Alloc. 2012 Feb 1;10(1):1.

Gunnels C, Alkire JK, Bonilla R, Ferrise A, Ghanem N. Butterfly distribution across FGCU campus as a measure of ecosystem health. Poster presented at the 2012 FGCU Research Day; 2012. Fort Myers, FL.

Kiladjian J, Al-Ali H, Gisslinger H, Knoops L, Waltzman RJ, Mendelson E, Copley-Merriman K. Health-related quality of life and symptoms in myelofibrosis patients treated with ruxolitinib versus best available therapy. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):795. doi: 10.1182/blood.V118.21.795.795

Walter JW, Spinner DS, Birt J, Bowman L, Mauskopf JA, Drummond M, Copley-Merriman K. Clinical and economic evidence bases for health technology assessment: a comparison of three jurisdictions. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain.

Spinner DS, Mladsi D, Walter J, Ziemiecki R, Stafford-Smith M, Taekman J, Faulkner E. Clinical trial learning curves may impact both clinical and economic outcomes and influence health technology assessment and reimbursement decision making. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A356.

Sood V, Braun L, Hogue S, Davis K, Copley-Merriman C, Lieberman B. Chronic kidney disease burdens patients, health care systems, and employers. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A331.

Sennfalt K, Ling CS, Pericleous L, Sbarigia U, Gatta F, Kolasa K, Chamberlain G, Pandit P, Zagorska G. The economic burden of post-transplant events in renal transplant patients in UK, Italy, Netherlands, Poland and Belgium. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2011. [abstract] Value Health. 2011 Nov; 14(7):A262-3.

Colosia A, Levine M. How to incorporate information from professional meeting abstracts into a literature search or other project. Poster presented at the 2011 71st Annual American Medical Writer’s Association (AMWA) Conference; October 2011. Jacksonville, FL.

Mordin M, Clark M, DeMuro C, Evans ED, Copley-Merriman K, Fehnel S, Gnanasakthy A. Pro label claims: an analysis based on a review of pros among new molecular entities and biologic license applications 2006-2010. Poster presented at the 2011 ISPOR 16th Annual International Meeting; June 3, 2011. [abstract] Value Health. 2011 May; 14(3):A29.

Coleman C, Chang S, Copley-Merriman K, Masaquel CJ, Hubble J. Health-related quality-of-life improvements with dysport in cervical dystonia. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 26, 2011. [abstract] Value Health. 2011 May; 14(3):A210.

D'Souza V, Dancer R, Rajesh PB, Tetley T, Thickett DR. Differential effects of VEGF upon primary alveolar epithelial cells during transdifferentiation. Poster presented at the ERS Lung Science Conference; April 2011. Estoril, Portugal.

Colosia AD, Peltz G, Pohl G, Liu E, Copley-Merriman K, Khan S, Kaye JA. A review and characterization of the various perceptions of quality cancer care. Cancer. 2011 Mar 1;117(5):884-96.

Zhao H, Yang J, Shan L, Jorgersen ED. Measuring the impact of cigarette smoke on the UPR. In: P. Michael Conn, editors. Methods in enzymology. Academic Press; 2011. p.147-64. doi: 10.1016/B978-0-12-385116-1.00009-1.

Alkire JK, Fugate D, Thomas S. The nutritional adequacy of gluten-free and casein-free diet in children with autism. Poster presented at the 2011 Scientific Process Research Proposal Day; 2011. Fort Myers, FL.

Rycroft CE, Pearson IV, Khan S, Heyes AE. A tale of four countries: comparing reimbursement submission requirements in Ireland, England, Wales, and Scotland. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A418-9.

Norquist J, Nixon A, Copley-Merriman K. Documenting PRO evidence for EMA and FDA submissions to support promotional and labeling claims. Poster presented at the International Society for Quality of Life Research Workshop #12; October 2010.

Khan SB, Peltz G, Pohl G, Liu E, Copley-Merriman K, Colosia AD. Impact of patient/provider communications on quality of care for cancer. Poster presented at the 3rd Conference of the American Association for Cancer Research; October 2010.

Chakrabarti L, Best TK, Cramer NP, Carney RSE, Isaac JTR, Galdzicki Z, Haydar TF. Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci. 2010 Aug;13(8):927-34. doi: 10.1038/nn.2600

D'Souza V, Dancer RCA, Thickett DR. Vascular endothelial growth factor in acute lung injury. In: Vincent JL, editors. The yearbook of intensive care and emergency medicine 2010. Berlin: Germany. Springer Berlin Heidelberg; 2010. p.121-8. doi: 10.1007/978-3-642-10286-8_12

Copley-Merriman K, Peltz G, Pohl G, Liu E, Kaye JA. Impact of race/ethnicity and health insurance status on quality of care for cancer. Poster presented at the Annual Meeting of the American Society of Clinical Oncology; June 2010.

Carney RS, Mangin JM, Hayes L, Mansfield K, Sousa VH, Fishell G, Machold RP, Ahn S, Gallo V, Corbin JG. Sonic hedgehog expressing and responding cells generate neuronal diversity in the medial amygdala. Neural Dev. 2010 May 27;5(14). doi: 10.1186/1749-8104-5-14

Colosia AD, Khan SB, Peltz G, Pohl G, Liu E, Kaye JA. Electronic medical records: quality cancer care and cost-effectiveness. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010. [abstract] Value Health. 2010 May; 13(3):A52.

Mordin MM, Lewis SA, Gnanasakthy A, DeMuro-Mercon CJ, Copley-Merriman K, Fehnel SE. Patient-reported outcomes in product development guidance. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 1, 2010. Atlanta, GA. [abstract] Value Health. 2010 May; 13(3):A-17-8.

Khan SB, Faulkner E, Watkins J, Polkus V. Making a case for value: differences in dossier development and value communication for pharmaceuticals versus diagnostics and medical devices. Presented at the 2010 ISPOR 15th Annual International Meeting; May 2010. Atlanta, GA.

Mordin M, Lewis SE, Gnanasakthy A, Demuro-Mercon C, Copley-Merriman K, Fehnel S. Patient-reported outcomes as mentioned in product development guidance. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 4, 2010. [abstract] Value Health. 2010 May; 13(3):A17-8.

Faulkner EC, Khan SB. Dossiers for diagnostics or medical devices. Poster presented at the 22nd Annual Meeting and Showcase of the Academy of Managed Care Pharmacy; April 2010.

Rofail D, Kitchen H, Heyes A, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: the humanistic and economic burden. Poster presented at the American Neurological Association; 2010. San Francisco, CA.

Cocas LA, Miyoshi G, Carney RSE, Sousa VH, Hirata T, Jones KR, Fishell G, Huntsman MM, Corbin JG. Emx1-lineage progenitors differentially contribute to neural diversity in the striatum and amygdala. J Neurosci. 2009 Dec 16;29(50):15933-46. doi: 10.1523/JNEUROSCI.2525-09.2009

Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009 Nov 1;10(16):2581-92. doi: 10.1517/14656560903304063.

Zimovetz E, Wolowacz S. Reviewer's checklist for assessing the quality of decision models. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. [abstract] Value Health. 2009 Oct; 12(7):A395.

de Cambra S, Mladsi D, Neale S, Faulkner EC. Reimbursement of active immunotherapeutics: an analysis based on a study of current reimbursement approaches. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A288. doi: 10.1111/j.1524-4733.2009.00592_1.x

de Cambra S, Mladsi D, Neale S. International payer research: comparing and contrasting payer roles and research methods in Canada, Spain, and the UK. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A245. doi: 10.1111/j.1524-4733.2009.00592_1.x

Hoe H-S, Lee KJ, Carney RSE, Lee J, Markova A, Lee J-Y, Howell BW, Hyman BT, Pak DTS, Bu G, Rebeck GW. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci. 2009 Jun 10;29(23):7459-73. doi: 10.1523/JNEUROSCI.4872-08.2009

Copley-Merriman K, Barrows SM, Whiteley J, Barrett AM. Value messages: developing, incorporating, and making use of a core strategic tool. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 28, 2009.

Juniper MD, Gaich C, Frear R, Sweet B. Adhering to multiple guidelines for preparation of formulary submission dossiers: aligning with payer expectations. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 27, 2009.

Copley-Merriman K, Barrett AM, Barrows SM, Whiteley J. Understanding and transmitting the value of a new drug. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009.

Mordin MM, Clark M, Siersma CA, Copley-Merriman K, Gnanasakthy A. Impact of the FDA draft guidance on patient reported outcomes (PRO) label claims for approved drug products in the US: has it made a difference? Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 19, 2009. Orlando, FL. [abstract] Value Health. 2009 May; 12(3):A29.

Khan SB, Zagar AJ, Hayes CP, DiBenedetti DB, Zhou X, Price M, Van Brunt DL. Assessment of type 2 Diabetes mellitus patients with and without symptoms of ADHD: patient characteristics and resource utilization data from an internet-based survey. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL. [abstract] Value Health. 2009 May 1; 12(3):A181-2.

Carney RSE, Cocas LA, Hirata T, Mansfield K, Corbin JG. Differential regulation of telencephalic pallial-subpallial boundary patterning by Pax6 and Gsh2. Cereb Cortex. 2009 Apr;19(4):745-59. doi: 10.1093/cercor/bhn123

O'Connor DB, Warttig S, Conner M, Lawton R. Raising awareness of hypertension risk through a web-based framing intervention: does consideration of future consequences make a difference? Psychol Health Med. 2009 Mar;14(2):213-9. doi: 10.1080/13548500802291618

Arbuckle R, Atkinson MJ, Clark M, Abetz L, Lohs J, Kuhagen I, Harness J, Draelos Z, Thiboutot D, Blume-Peytavi U, Copley-Merriman K. Patient experiences with oily skin: the qualitative development of content for two new patient reported outcome questionnaires. Health Qual Life Outcomes. 2008 Oct 16;6:80. doi: 10.1186/1477-7525-6-80.

Jorgensen E, Stinson A, Shan L, Yang J, Gietl D, Albino AP. Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer. 2008 Aug 11;8:229. doi: 10.1186/1471-2407-8-229

Juniper MD, McCrink L, Mladsi DM, Le TK. The burden of fibromyalgia in France, Germany, Italy, Spain, and the UK: a literature-based review. Poster presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.

Copley-Merriman C, Fehnel SE, Chandler J, Wild D. Obtaining a patient-reported outcomes label claim: what evidence do you need? Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008.

Slotkin JR, Chakrabarti L, Dai HN, Carney RSE, Hirata T, Bregman BS, Gallicano GI, Corbin JG, Haydar TF. In vivo quantum dot labeling of mammalian stem and progenitor cells. Dev Dyn. 2007 Dec;236(12):3393-401. doi: 10.1002/dvdy.21235

Xu X, Mordin MM. Determine measurement properties of a pro instrument. Poster presented at the CBI's Premier Conference on Patient-Reported Outcomes (PRO); November 2007.

Hutchison RW, Anastassopoulos K, Vallow S, Mordin M, Olson W, Hewitt D, Sikirica V. Intravenous patient-controlled analgesia pump and reservoir logistics: results from a multicenter questionnaire. Hosp Pharm. 2007 Nov 1;42(11):1036-44.

Jansen JP, Evans CE, Guyot P, Masaquel CJ, Mayne TJ. The impact of epoetin alfa on the symptoms of anemia: a Bayesian meta-analysis of clinical trials. Poster presented at the American Society of Nephrology; November 2007.

Jansen JP, Evans CE, Guyot P, Masaquel CJ, Mayne TJ. The effect of epoetin alfa on physical functioning: a literature review. Poster presented at the American Society of Nephrology Program; November 2007.

Mordin M, Anastassopoulos K, van Breda A, Vallow S, Zhang M, Gargiulo K, Hewitt D, Olson W, Sikirica V. Clinical staff resource use with intravenous patient-controlled analgesia in acute postoperative pain management: results from a multicenter, prospective, observational study. J Perianesth Nurs. 2007 Aug 1;22(4):243-55.